Skip to main content

Clinical Trial Results


Dr. Dean Kereiakes and Dr. C. Michael Gibson Discuss: First Human Use of a Novel Subcutaneous Platelet GPIIb/IIIa Inhibitor (RUC-4) Designed for STEMI Point of Care Treatment

Tags: , ,
Loader Loading…
EAD Logo Taking too long?

Reload Reload document
| Open Open in new tab


Disclosures: TBA